Knowledge of and willingness to take pre-exposure prophylaxis among men who have sex with men in Israel.

ABSTRACT:

Background

Oral pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) has been found to reduce viral acquisition among HIV-negative MSM. This cross-sectional study was conducted before pre-exposure prophylaxis (PrEP) licensure in Israel, and aimed to compare men who have sex with men (MSM) who had heard of PrEP with those who had not, as well as MSM willing to take PrEP with those who were hesitant or not willing to take PrEP.

Methods

HIV-negative MSM responded anonymously to questionnaires in 2017 regarding their knowledge of and willingness to take PrEP, prior use of PrEP and post-exposure prophylaxis (PEP), and their sexual behaviors.

Results

Among 1705 participants, 1431 (83.9%) had heard about PrEP. They were older and mor

SUBMITTER: Zohar M 

PROVIDER: S-EPMC8647505 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature